科研之友
微信
新浪微博
Facebook
分享链接
摘要
TGF-beta is an immunoregulatory protein that contributes to inadequate antitumor immune responses in cancer patients. Recent experimental data suggests that TGF-beta inhibition alone, provides few clinical benefits, yet it can significantly amplify the anti-tumor immune response when combined with a tumor vaccine. We develop a mathematical model in order to gain insight into the cooperative interaction between anti-TGF-beta and vaccine treatments. The mathematical model follows the dynamics of the tumor size, TGF-beta concentration, activated cytotoxic effector cells, and regulatory T cells. Using numerical simulations and stability analysis, we study the following scenarios: a control case of no treatment, anti-TGF-beta treatment, vaccine treatment, and combined anti-TGF-beta vaccine treatments. We show that our model is capable of capturing the observed experimental results, and hence can be potentially used in designing future experiments involving this approach to immunotherapy.
- 出版日期2012-7
